Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple Sclerosis (IQUALYSEP)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2012 by Rennes University Hospital
Information provided by (Responsible Party):
Rennes University Hospital Identifier:
First received: February 8, 2010
Last updated: November 30, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2019
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)